Evidence map›Paper›PMID 35585776›Full record

ArticleMuscle & nerve2022

Utility of the ALSFRS-R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank.

Leigh E Colvin, Zachariah W Foster, Thor D Stein, Manisha Thakore-James, Mohammad Kian Salajegheh, Kendall Carr, Keith R Spencer, Nazifa Abdul Rauf, Latease Adams, James G Averill and 7 more

Open access · greenAbstract read
In one paragraph

Article in Muscle & nerve, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Leigh E ColvinVA Boston Healthcare System, Boston, Massachusetts, USA.ORCID 0000-0002-6806-1147
Zachariah W FosterVA Boston Healthcare System, Boston, Massachusetts, USA.ORCID 0000-0002-5813-5202
Thor D SteinVA Boston Healthcare System, Boston, Massachusetts, USA.
Manisha Thakore-JamesVA Boston Healthcare System, Boston, Massachusetts, USA.
Mohammad Kian SalajeghehVA Boston Healthcare System, Boston, Massachusetts, USA.
Kendall CarrVA Boston Healthcare System, Boston, Massachusetts, USA.
Keith R SpencerVA Boston Healthcare System, Boston, Massachusetts, USA.
Nazifa Abdul RaufVA Boston Healthcare System, Boston, Massachusetts, USA.
Latease AdamsVA Boston Healthcare System, Boston, Massachusetts, USA.
James G AverillSouthern Arizona VA Healthcare System, Tucson, Arizona, USA.
Sean E WalkerSouthern Arizona VA Healthcare System, Tucson, Arizona, USA.
Ian RobeySouthern Arizona VA Healthcare System, Tucson, Arizona, USA.
Victor E AlvarezVA Boston Healthcare System, Boston, Massachusetts, USA.
Bertrand R HuberVA Boston Healthcare System, Boston, Massachusetts, USA.
Ann C McKeeVA Boston Healthcare System, Boston, Massachusetts, USA.
Neil W KowallVA Boston Healthcare System, Boston, Massachusetts, USA.
Christopher B BradyVA Boston Healthcare System, Boston, Massachusetts, USA.ORCID 0000-0002-6095-6480
Boston University · USVA Boston Healthcare System · USSouthern Arizona VA Health Care System · USHarvard University · US

Funding

Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
Age-Associated Lipidomic Changes in Alzheimer's DiseaseRF1AG057768 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLUSZTAJN, JAN KRZYSZTOF, STEIN, THOR · 2019 to 2021
$4.5M
Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies andcognitive declineRF1AG054156 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, RYU, HOON · 2016 to 2018
$3.4M
Age-Associated Lipidomic Changes in Alzheimer's DiseaseR56AG057768 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLUSZTAJN, JAN KRZYSZTOF, STEIN, THOR · 2017 to 2017
$820k
VA Biorepository: Gulf War Veterans' Illnesses BiorepositoryI01BX003063 · VA · VA BOSTON HEALTH CARE SYSTEM · PI HUBER, BERTRAND R, PIERCE, MEGHAN E · 2015 to 2025
–
The neuropathology of mild traumatic brain injury in Alzheimer's diseaseI01CX001038 · VA · EDITH NOURSE ROGERS MEMORIAL VETERANS HOSPITAL · PI STEIN, THOR · 2015 to 2022
–
VA Biorepository Brain BankI01BX002466 · VA · VA BOSTON HEALTH CARE SYSTEM · PI Ann C. McKee, Haining Zhu · 2014 to 2026
–
BLRD VA I01 BX002466BLRD VA I01 BX003063BLRD VA I01 BX005161CSRD VA I01 CX001038NIA NIH HHS P30 AG013846NIA NIH HHS R56 AG057768NIA NIH HHS RF1 AG054156NIA NIH HHS RF1 AG057768
6 · The paper itself

Abstract

INTRODUCTION/

aimsThe amyotrophic lateral sclerosis (ALS) functional rating scale-revised (ALSFRS-R) is commonly used to track ALS disease progression; however, there are gaps in the literature regarding the extent to which the ALSFRS-R relates to underlying central nervous system (CNS) pathology. The current study explored the association between ALSFRS-R (total and subdomain) scores and postmortem neuropathology (both ALS-specific and comorbid disease).

methodsWithin our sample of 93 military veterans with autopsy-confirmed ALS, we utilized hierarchical cluster analysis (HCA) to identify discrete profiles of motor dysfunction based on ALSFRS-R subdomain scores. We examined whether emergent clusters were associated with neuropathology. Separate analyses of variance and covariance with post-hoc comparisons were performed to examine relevant cluster differences.

resultsAnalyses revealed significant correlations between ALSFRS-R total and subdomain scores with some, but not all, neuropathological variables. The HCA illustrated three groups: Cluster 1-predominantly diffuse functional impairment; Cluster 2-spared respiratory/bulbar and impaired motor function; and Cluster 3-spared bulbar and impaired respiratory, and fine and gross motor function. Individuals in Cluster 1 (and to a lesser degree, Cluster 3) exhibited greater accumulation of ALS-specific neuropathology and less comorbid neuropathology than those in Cluster 2. DISCUSSION: These results suggest that discrete patterns of motor dysfunction based on ALSFRS-R subdomain scores are related to postmortem neuropathology. Findings support use of ALSFRS-R subdomain scores to capture the heterogeneity of clinical presentation and disease progression in ALS, and may assist researchers in identifying endophenotypes for separate assessment in clinical trials.

Indexed as

Amyotrophic Lateral SclerosisVeteransBrainDisease ProgressionHumansSeverity of Illness Indexamyotrophic lateral sclerosiscluster analysisfunctional rating scaleneuropathology

Identifiers

PMID35585776
PMCPMC9308705
OpenAlexW4280505670

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.